GRadient echo Acquisition for Superparamagnetic particles with Positive contrast (GRASP): Sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T

Magnetic Resonance in Medicine

Volumn 55, Issue 1, 2006, Pages 126-135

  Mani, Venkatesh ^a   Briley Saebo, Karen C ^a   Itskovich, Vitalii V ^a   Samber, Daniel D ^a   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gradient echo imaging; Iron oxide; Positive contrast MRI; Susceptibility; T2*

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; PHANTOMS; SUPERPARAMAGNETISM;

CELL TRAFFICKING; GRADIENT ECHO; GRADIENT ECHO IMAGING; MRI SEQUENCES; POSITIVE SIGNALS; SEQUENCE CHARACTERIZATION; SUPERPARAMAGNETIC IRON OXIDES; SUPERPARAMAGNETIC PARTICLES;

IRON OXIDES;

SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; GRADIENT ECHO ACQUISITION FOR SUPERPARAMAGNETIC PARTICLES WITH POSITIVE CONTRAST; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM;

EID: 30344439136     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20739     Document Type: Article

References (25)

1. Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 2004;182:1217-1223.
2. Bulte JW, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol 2004;386:275-299.
3. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005;105:420-425.
4. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady TJ, Ferrucci JT Jr. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 1987;162:211-216.
5. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989;152:167-173.
6. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498.
7. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493.
8. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994;193:501-506.
9. Anzai Y, Prince MR, Chenevert TL, Maki JH, Londy F, London M, McLachlan SJ. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997;7:209-214.
10. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas JF, Blezer E, Rausch M, Brochet B, Foster-Gareau P, Baleriaux D, Gaillard S, Dousset V. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiology 2004;39:619-625.
11. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415-422.
12. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107:2453-2458.
13. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005;53:999-1005.
14. Heyn C, Bowen CV, Rutt BK, Foster PJ. Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med 2005;53:312-320.
15. th Annual Meeting of ISMRM, Miami Beach, FL, 2005.
16. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50:784-790.
17. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13:661-674.
18. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32:749-763.
19. Gillis P, Moiny F, Brooks RA. On T(2)-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med 2002;47:257-263.
20. Day Jr RA, Underwood, AL. Errors and the treatment of analytical data. Quantitative analysis. 4th ed. Englewood Cliffs, NJ: Prentice-Hall Inc.; 1980. p 31.
21. Dahnke H, Schaeffter T. Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn Reson Med 2005;53:1202-1206.
22. Hardy P, Henkelman RM. On the transverse relaxation rate enhancement induced by diffusion of spins through inhomogeneous fields. Magn Reson Med 1991;17:348-356.
23. Weissleder R, Papisov M. Pharmaceutical iron oxides for MR imaging. Reviews of Magnetic Resonance in Medicine 1992;4:1-20.
24. Wang YXJ, Hussain SM, Kiestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiology 2001;11:2319-2331.
25. Majumdar S, Zoghbi SS, Gore JC. The influence of pulse sequence on the relaxation effects of superparamagnetic iron-oxide contrast agents. Magnet Reson Med 1989;10:289-301.